Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Diaceutics (DXRX) Share Price

Price 117.00p on 20-06-2025 at 18:50:05
Change 0.00p 0%
Buy 118.00p
Sell 116.00p
Buy / Sell DXRX Shares
Last Trade: Buy 1.00 at 118.00p
Day's Volume: 582,993
Last Close: 117.00p
Open: 117.00p
ISIN: GB00BJQTGV64
Day's Range 117.00p - 117.00p
52wk Range: 107.50p - 151.00p
Market Capitalisation: £99m
VWAP: 117.09151p
Shares in Issue: 85m

Diaceutics (DXRX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1 118.00p Ordinary
14:47:24 - 20-Jun-25
Unknown* 10,000 117.00p Ordinary
11:55:28 - 20-Jun-25
Unknown* 7,264 117.00p Ordinary
11:54:59 - 20-Jun-25
Unknown* 150,000 117.00p Negotiated Trade
11:40:18 - 20-Jun-25
Unknown* 154,820 117.00p Negotiated Trade
11:39:53 - 20-Jun-25
Unknown* 33,000 117.00p Ordinary
11:13:54 - 20-Jun-25
Unknown* 48,000 117.00p Negotiated Trade
11:13:14 - 20-Jun-25
Unknown* 50,000 117.00p Negotiated Trade
11:06:36 - 20-Jun-25
Unknown* 50,000 117.00p Negotiated Trade
11:06:29 - 20-Jun-25
Buy* 15,000 117.80p Ordinary
10:52:45 - 20-Jun-25
See more Diaceutics trades

Diaceutics (DXRX) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Jun 2025 (Fri) 117.00 117.00 117.00 117.00 582,993
19th Jun 2025 (Thu) 118.00 118.00 117.00 117.00 1,050
18th Jun 2025 (Wed) 120.50 120.50 116.50 117.00 109,522
17th Jun 2025 (Tue) 125.00 123.00 120.50 120.50 173,391
16th Jun 2025 (Mon) 123.00 125.50 123.00 125.00 13,003
13th Jun 2025 (Fri) 125.50 125.50 125.00 125.50 34,072
12th Jun 2025 (Thu) 126.00 126.00 125.50 125.50 30,399
11th Jun 2025 (Wed) 127.00 127.50 126.00 126.00 23,094
10th Jun 2025 (Tue) 128.00 126.00 126.00 126.00 315,317
9th Jun 2025 (Mon) 130.00 130.00 129.00 129.00 56,231
6th Jun 2025 (Fri) 133.00 136.00 127.00 129.00 101,149
5th Jun 2025 (Thu) 129.50 133.00 129.50 133.00 83,495
4th Jun 2025 (Wed) 126.50 129.00 126.50 129.00 38,654
3rd Jun 2025 (Tue) 137.50 126.50 125.00 126.50 329,275
2nd Jun 2025 (Mon) 139.00 139.00 137.50 137.50 24,861
30th May 2025 (Fri) 137.50 137.50 137.50 137.50 73,604
29th May 2025 (Thu) 137.50 137.50 137.50 137.50 30,163
28th May 2025 (Wed) 139.00 137.50 135.00 137.50 29,154
27th May 2025 (Tue) 139.00 142.00 139.00 139.00 5,587
26th May 2025 (Mon) 138.60 138.60 138.60 138.60 0
23rd May 2025 (Fri) 141.00 144.00 139.00 139.00 410,230
22nd May 2025 (Thu) 139.00 139.50 139.00 139.50 179,790
21st May 2025 (Wed) 134.50 141.00 131.00 139.00 232,144
See more Diaceutics price history

Diaceutics (DXRX) Regulatory News

Date Source Headline
18th Jun 2025 12:00 pm RNS Results of AGM
6th Jun 2025 9:33 am RNS PDMR Shareholding /Share Incentive Plan and TVR
21st May 2025 5:00 pm RNS Notice of AGM and Posting of Annual Report
15th May 2025 7:00 am RNS Transaction by Persons Closely Associated to PDMRs
13th May 2025 7:00 am RNS FY 2024 Results - Strong Revenue Growth
29th Apr 2025 4:09 pm RNS PDMR Shareholding/Share Incentive Plan and TVR
29th Apr 2025 7:00 am RNS Notice of Results
7th Apr 2025 10:33 am RNS Block Listing Return
3rd Apr 2025 1:54 pm RNS PDMR Shareholding/Share Incentive Plan and TVR
26th Mar 2025 7:00 am RNS PMx Promotional Partner Contract Enhancement
See more Diaceutics regulatory news

Diaceutics (DXRX) Share News

IN BRIEF: Diaceutics chair sells 500,000 shares after results release

19th May 2025 08:15

Diaceutics PLC - Belfast-based provider of technology and solutions to the pharmaceutical and biotechnology industry - Delia Keeling, spouse of Chair Peter Keeling sells 500,000 shares at 126 pence, worth GBP630,000, on Tuesday last week. The Keelings now have 15.3 million shares, an 18% stake, down from 18.6%. Diaceutics earlier Tuesday had released its 2024 results. Its pretax loss narrowed to GBP1.9 million from GBP2.4 million in 2023, as revenue rose 36% to GBP32.2 million from GBP23.7 million. Read More

Diaceutics narrows loss, grows revenue in "another strong year"

13th May 2025 10:58

(Alliance News) - Diaceutics PLC on Tuesday reported increased revenue in 2024, and said it expects to return to profitability this year. Read More

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

29th Jan 2025 15:48

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Diaceutics opens new US headquarters in New Jersey

14th Jan 2025 15:51

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Opens new US headquarters in Newport, New Jersey. Says the new office is close to most of its life science customers in the northeastern US. The US market represents 90% of its revenue. The company says it will expand its US sales and marketing operations. Read More

Diaceutics launches new engagement service with 12-month contract win

8th Jan 2025 10:09

(Alliance News) - Diaceutics PLC on Wednesday said it has launched its new pathology engagement liaisons service, and secured a new 12-month contract worth up to USD1.8 million. Read More

See more Diaceutics news
FTSE 100 Latest
Value8,774.65
Change-17.15

Login to your account

Forgot Password?

Not Registered